Giuseppe Floresta - Search Results

Year	Number of Results
2017	10
2018	14
2019	14
2020	12
2021	8
2022	0

1

Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?

Arena E, Dichiara M, Floresta G, Parenti C, Marrazzo A, Pittalà V, Amata E, Prezzavento O. Arena E, et al. Among authors: floresta g. Future Med Chem. 2018 Jan;10(2):231-256. doi: 10.4155/fmc-2017-0164. Epub 2017 Nov 29. Future Med Chem. 2018. PMID: 29185346 Review.

2

Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.

Salerno L, Floresta G, Ciaffaglione V, Gentile D, Margani F, Turnaturi R, Rescifina A, Pittalà V. Salerno L, et al. Among authors: floresta g. Eur J Med Chem. 2019 Apr 1;167:439-453. doi: 10.1016/j.ejmech.2019.02.027. Epub 2019 Feb 12. Eur J Med Chem. 2019. PMID: 30784878 Review.

3

The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat.

Zagni C, Floresta G, Monciino G, Rescifina A. Zagni C, et al. Among authors: floresta g. Med Res Rev. 2017 Nov;37(6):1373-1428. doi: 10.1002/med.21437. Epub 2017 Feb 9. Med Res Rev. 2017. PMID: 28181261 Review.

4

Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents.

Dichiara M, Amata E, Rescifina A, Prezzavento O, Floresta G, Parenti C, Pittalà V, Marrazzo A. Dichiara M, et al. Among authors: floresta g. Future Med Chem. 2017 Oct;9(15):1749-1764. doi: 10.4155/fmc-2017-0064. Epub 2017 Sep 4. Future Med Chem. 2017. PMID: 28869398 Review.

5

Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review.

Floresta G, Pistarà V, Amata E, Dichiara M, Marrazzo A, Prezzavento O, Rescifina A. Floresta G, et al. Eur J Med Chem. 2017 Sep 29;138:854-873. doi: 10.1016/j.ejmech.2017.07.022. Epub 2017 Jul 15. Eur J Med Chem. 2017. PMID: 28738306 Review.

6

Growing the molecular architecture of imidazole-like ligands in HO-1 complexes.

Floresta G, Fallica AN, Salerno L, Sorrenti V, Pittalà V, Rescifina A. Floresta G, et al. Bioorg Chem. 2021 Dec;117:105428. doi: 10.1016/j.bioorg.2021.105428. Epub 2021 Oct 20. Bioorg Chem. 2021. PMID: 34710668

7

Towards identifying nicomorphine administration in doping control: synthesis of metabolites.

Floresta G, Gavrilović I, Devey S, Harris R, Cowan D, Abbate V. Floresta G, et al. Bioanalysis. 2021 Sep;13(18):1415-1425. doi: 10.4155/bio-2021-0076. Epub 2021 Sep 16. Bioanalysis. 2021. PMID: 34528849

8

Sigma-2 receptor ligands QSAR model dataset.

Rescifina A, Floresta G, Marrazzo A, Parenti C, Prezzavento O, Nastasi G, Dichiara M, Amata E. Rescifina A, et al. Among authors: floresta g. Data Brief. 2017 Jun 16;13:514-535. doi: 10.1016/j.dib.2017.06.022. eCollection 2017 Aug. Data Brief. 2017. PMID: 28702490 Free PMC article.

9

Illuminating the Path to Target GPCR Structures and Functions.

Nielsen CD, Dhasmana D, Floresta G, Wohland T, Cilibrizzi A. Nielsen CD, et al. Among authors: floresta g. Biochemistry. 2020 Oct 13;59(40):3783-3795. doi: 10.1021/acs.biochem.0c00606. Epub 2020 Sep 29. Biochemistry. 2020. PMID: 32956586

10

Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity.

Fallica AN, Sorrenti V, D'Amico AG, Salerno L, Romeo G, Intagliata S, Consoli V, Floresta G, Rescifina A, D'Agata V, Vanella L, Pittalà V. Fallica AN, et al. Among authors: floresta g. J Med Chem. 2021 Sep 23;64(18):13373-13393. doi: 10.1021/acs.jmedchem.1c00633. Epub 2021 Sep 2. J Med Chem. 2021. PMID: 34472337 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results